Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors; Author, Entrepreneur, and Board Management Expert Joins Other National Leaders Advising Natrol.

CHATSWORTH, Calif. -- Natrol, Inc. (NASDAQ:NTOL), a premier manufacturer and distributor of nationally branded nutritional products, today announced that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors.

"Tom Doorley is a leader of the highest integrity, with expertise as a corporate strategist who builds and advises growth-focused companies, assisting them to achieve superior performance," said Wayne Bos, CEO-designate of Natrol. "We look forward to leveraging Tom's combined global growth and governance skills to benefit Natrol as it moves towards expanding its place in the global marketplace."

Widely regarded as an expert on performance and growth, Mr. Doorley is the author of "Value-Creating Growth: How to Lift Your Company to the Next Level of Performance," and its predecessor, "Le Modele de Croissance." These, and an earlier book, "Teaming Up for the 90s: A Guide to International Joint Ventures and Strategic Alliances," have been published in several languages.

"It is an exciting time for Natrol as the depth of the company is expanded, and I am very proud to welcome Mr. Doorley onto the Board of Directors of Natrol," said Executive Chairman, Elliott Balbert.

"Natrol is a developer and distributor of high-quality nutritional products and operates in a market that is strong and should become stronger. It is a very attractive Board on which to serve," said Mr. Doorley. "I believe in an active, engaged and knowledgeable Board - one that takes seriously its charge to 'protect and enhance' the value of the enterprise for shareholders. I am extremely pleased to join the Natrol Board, and contribute my skills to the Company."

Mr. Doorley is co-founder of Braxton Associates, which he launched, successfully globalized, and engineered into a value-creating merger with Deloitte and Touche. The merged enterprise is now a $500 Million business with more than 1,000 professionals. His clients were the senior leadership teams and Boards in a broad range of industries, especially consumer-related businesses. He also directed Deloitte's research and client initiatives as the leader of its Global Growth Initiative. Based on this work, he was elected the inaugural Chair of the World Economic Forum's Technology Pioneers, and founded, then chaired, the Technology Empowerment Network. Mr. Doorley also serves as a Board member for StratBridge (US), and is on the Dean's Advisory Board at The Pennsylvania State University, where he chairs the Chemical Engineering Committee.

Mr. Doorley holds an M.B.A. with Highest Honors from Columbia University, where he was awarded a Woodrow Wilson Fellowship, was elected to Beta Gamma Sigma, and was named the outstanding graduate in marketing by the American Marketing Association. He also holds a B.S. in Chemical Engineering and a B.A. in Arts and Sciences from The Pennsylvania State University.

The Natrol Board of Directors includes Executive Chairman and Founder, Elliott Balbert, Wayne M. Bos, Senator Dennis DeConcini, Vernon Brunner, Dennis Jolicoeur and Ronald Consiglio. For further information, visit www.natrol.com.

About Natrol

Founded in 1980, Natrol, Inc. (NASDAQ:NTOL) is a diversified nutrition company that manufactures and markets premium branded nutritional products, functional teas and sports fitness products under the Natrol(R), Laci Le Beau(R) Tea and Prolab(R) Sports Nutrition labels. Natrol markets more than 200 nutritional products designed to meet a wide range of consumer needs. The products are available at more than 50,000 food, drug, mass market and independent health food stores, catalogs and Internet sites, gyms and specialty stores nationally and in select foreign countries. For more information, visit www.natrol.com.

The statements made in this press release which are not historical facts including statements regarding expectations for future growth of revenue and profits and trends concerning net sales, are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. As a result of a number of factors, the Company's actual results could differ materially from those set forth in the forward looking statements. Certain factors that might cause Natrol's actual results to differ materially from those set forth in the forward looking statements include adverse trends in the dietary supplements industry, intense competition, adverse effects of unfavorable publicity regarding particular products or the Company's industry generally, the Company's dependence on the introduction of successful new products, the Company's ability to gain market share and shelf space in each of its distribution channels, the Company experiencing high rates of product returns, and adverse government regulation, as well as those factors set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2004 and in the Company's other filings with Securities and Exchange Commission.